Question 1

What is the catalog number for Biotin-Linked Polyclonal Antibody to Glutamate Receptor, Ionotropic, AMPA 2 (GRIA2)?

Accepted Answer

The catalog number for Biotin-Linked Polyclonal Antibody to Glutamate Receptor, Ionotropic, AMPA 2 (GRIA2) is MBS2095850.

Question 2

Is Biotin-Linked Polyclonal Antibody to Glutamate Receptor, Ionotropic, AMPA 2 (GRIA2) in stock?

Accepted Answer

Biotin-Linked Polyclonal Antibody to Glutamate Receptor, Ionotropic, AMPA 2 (GRIA2) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Question 4

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 5

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Biotin-Linked Polyclonal Antibody to Glutamate Receptor, Ionotropic, AMPA 2 (GRIA2)

Product Specifications

CAS Number

Available Sizes

Frequently Asked Questions

Explore Other Products

Insulin-like Growth Factor-1 (IGF-1) (IGF1/2872R), CF594 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

RET Proto-oncogene (RET/2795), CF405S conjugate, 0.1mg/mL

Spectrin beta III (SPTBN2) (SPTBN2/2979R), CF405S conjugate, 0.1mg/mL

Ki-67 (Proliferating Cell Marker) (MKI67/2465), 0.2mg/mL

Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF405S conjugate, 0.1mg/mL